Home › Funds › Birchview Capital, LP › BCYC

Birchview Capital, LP position in BCYC

BICYCLE THERAPEUTICS PLC · Health Care

Birchview Capital, LP reported holding 176,432 shares of BCYC (BICYCLE THERAPEUTICS PLC) in its Q3 2026 13F filing — a position valued at US$649K, representing 0.39% of its reported portfolio and ranking #45 among its reported holdings. Birchview Capital, LP has disclosed BCYC holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)176.43K sh
Reported value held$649.27K
Portfolio Weight0.39%
First reportedQ3 2025
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Birchview Capital, LP's BCYC position evolved

Birchview Capital, LP first disclosed a stake in BCYC in Q3 2025 at 154,000 shares (US$1.2M). The position peaked in Q4 2025 at 462,700 shares, worth US$3.3M. Across 5 filings, Birchview Capital, LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 176,432 shares valued at US$649K — a reduction of -137,184 shares quarter over quarter.. Notable position changes include a 200% increase in Q4 2025 (shares fell 34% over the following quarter), a 32% trim in Q2 2026 (shares fell 13% over the following quarter), a 44% trim in Q3 2026 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 154.00K $1.19M New
Q4 2025 462.70K $3.28M Add
Q1 2026 463.60K $2.15M Hold
Q2 2026 313.62K $1.33M Reduce
Q3 2026 176.43K $649.27K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BCYC and 13F data

BCYC (BICYCLE THERAPEUTICS PLC) is a Health Care company. 10 other funds we track also report a position in BCYC — the largest reported positions include BAKER BROS. ADVISORS LP (US$46.2M), FCPM III SERVICES B.V. (US$14.7M), Long Focus Capital Management, LLC (US$14.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BCYC

All BCYC fund holders →

FAQ

How long has Birchview Capital, LP held BCYC?

Birchview Capital, LP has disclosed BCYC holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Birchview Capital, LP's current position in BCYC?

As of Q3 2026, Birchview Capital, LP holds 176.43K shares of BCYC (BICYCLE THERAPEUTICS PLC), valued at $649.27K, representing 0.39% of its reported portfolio and ranking #45.

Has Birchview Capital, LP been buying or selling BCYC?

In the latest 13F filing (Q3 2026), Birchview Capital, LP reduced its position in BCYC. The position peaked in Q4 2025 at 462.70K shares.

Which other funds hold BCYC?

Other major institutional holders of BCYC include BAKER BROS. ADVISORS LP, FCPM III SERVICES B.V., Long Focus Capital Management, LLC, among 10 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.